loadpatents
name:-0.018656015396118
name:-0.014252901077271
name:-0.0016109943389893
MORNINGSTAR; MARSHALL Patent Filings

MORNINGSTAR; MARSHALL

Patent Applications and Registrations

Patent applications and USPTO patent grants for MORNINGSTAR; MARSHALL.The latest application filed is for "compounds and methods for the treatment of parasitic diseases".

Company Profile
1.12.15
  • MORNINGSTAR; MARSHALL - CAMBRIDGE MA
  • Morningstar; Marshall - Waltham MA
  • Morningstar; Marshall - Framingham MA
  • Morningstar; Marshall - Frederick MD
  • Morningstar; Marshall - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds And Methods For The Treatment Of Parasitic Diseases
App 20220162211 - COMER; EAMON ;   et al.
2022-05-26
Treatment Of Infections Of Toxoplasma Gondii And Closely Related Parasites
App 20220033404 - SIBLEY; L. DAVID ;   et al.
2022-02-03
Compounds and methods for the treatment of parasitic diseases
Grant 11,174,260 - Comer , et al. November 16, 2
2021-11-16
Compounds And Methods For The Treatment Of Parasitic Diseases
App 20200095253 - COMER; EAMON ;   et al.
2020-03-26
Compounds For The Treatment Of Multi-drug Resistant Bacterial Infections
App 20120108577 - Breault; Gloria ;   et al.
2012-05-03
Compounds for the treatment of multi-drug resistant bacterial infections
Grant 8,124,602 - Breault , et al. February 28, 2
2012-02-28
Compounds For The Treatment Of Multi-drug Resistant Bacterial Infections
App 20110092495 - Breault; Gloria ;   et al.
2011-04-21
Compounds for the treatment of multi-drug resistant bacterial infections
Grant 7,875,715 - Breault , et al. January 25, 2
2011-01-25
Compounds For The Treatment Of Multi-drug Resistant Bacterial Infections
App 20100152441 - Breault; Gloria ;   et al.
2010-06-17
Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
App 20090131444 - Reck; Folkert ;   et al.
2009-05-21
Programmable genotoxic agents and uses therefor
App 20090062236 - Essigmann; John M. ;   et al.
2009-03-05
Inhibitors of .alpha..sub.1 .beta..sub.2 integrin mediated cell adhesion
Grant 7,375,128 - Sircar , et al. May 20, 2
2008-05-20
Fused heterocycles as inhibitors of glutamate racemase(MURI)
Grant 7,371,757 - Morningstar , et al. May 13, 2
2008-05-13
Inhibitors of .alpha..sub.L.beta..sub.2 mediated cell adhesion
Grant 7,342,012 - Sircar , et al. March 11, 2
2008-03-11
Novel Fused Heterocycles and Uses Thereof
App 20070275954 - Basarab; Gregory ;   et al.
2007-11-29
Pyrazolo[3,4-d]pyrimidines inhibiting H. pylori infections
Grant 7,285,558 - Basarab , et al. October 23, 2
2007-10-23
Programmable genotoxic agents and uses therefor
Grant 7,169,611 - Essigmann , et al. January 30, 2
2007-01-30
Pyrazolo [3,4-d] pyrimidine derivatives and their use in the treatment of h.pylori infection
App 20070004761 - Basarab; Gregory ;   et al.
2007-01-04
Inhibitors of alpha l beta 2 integrin mediated cell adhesion
App 20050171174 - Sircar, IIa ;   et al.
2005-08-04
Inhibitors of alphaLbeta2 mediated cell adhesion
App 20050148602 - Sircar, Ila ;   et al.
2005-07-07
Inhibitors of .alpha.L.beta.2 mediated cell adhesion
Grant 6,897,225 - Sircar , et al. May 24, 2
2005-05-24
Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
Grant 6,894,068 - Michejda , et al. May 17, 2
2005-05-17
Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections
App 20040254183 - Basarab, Gregory ;   et al.
2004-12-16
Programmable genotoxic agents and uses therefor
App 20030220311 - Essigmann, John M. ;   et al.
2003-11-27
Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
App 20030191160 - Michejda, Christopher J. ;   et al.
2003-10-09
Substituted benzimidazoles, and methods of use thereof, for the inhibition of HIV reverse transcription and for the treatment of HIV infection
Grant 6,369,235 - Michejda , et al. April 9, 2
2002-04-09
Programmable genotoxic agents and uses therefor
Grant 5,879,917 - Essigmann , et al. March 9, 1
1999-03-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed